Trademark Overview
On Thursday, June 12, 2025, a trademark application was filed for MITOXCELAI with the United States Patent and Trademark Office. The USPTO has given the MITOXCELAI trademark a serial number of 99230657. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, June 23, 2026. This trademark is owned by SENOTHERAPEUTIX, Inc.. The MITOXCELAI trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical research services; Medical research in the field of mitochondrial health and mitochondrial disease; Medical research in the field of metabolic health and metabolic conditions; Medical research in the field of anti-aging; Medical research in the field of senescent cells; Medical research in the field of age-related disorders; Medical research in the field of neurodegenerative health and neurodegenerative disease; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Pharmaceutical research in the field of mitochondrial disease; Pharmaceutical research in the field of metabolic conditions; Pharmaceutical research in the field of neurodegenerative disease; Gene therapy research; Testing of pharmaceuticals for cell and gene therapies; Development of pharmaceuticals for cell and gene therapies
Medical services, namely, anti-aging services in the nature of providing preventative medical care and treatment of age-related disorders and age-related diseases; Medical services, namely, providing preventative care and treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Medical services in the field of mitochondrial health and mitochondrial disease; Medical services in the field of metabolic health and metabolic conditions; Medical services in the field of anti-aging; Medical services in the field of senescent cells; Medical services in the field of age-related disorders; Medical services in the field of neurodegenerative health and neurodegenerative disease; Medical advisory services; Medical testing services; Medical testing services relating to the diagnosis and treatment of disease
Synthesized peptides for the treatment of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for the treatment and prevention of cancer, age-related disorders, age-related diseases, skin conditions, radiation damage, obesity, mitochondrial disease, neurodegenerative disease, and metabolic conditions; Pharmaceutical preparations for gene therapy for the treatment of age-related disorders; Pharmaceutical preparations for gene therapy for the treatment of cancer; Medicated skin preparation for use in treating skin conditions, aging, mitochondrial conditions, and senescent cells
